These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 22537291

  • 1. Preparation, characterization, and in vivo evaluation of triamcinolone acetonide microspheres after intravitreal administration.
    Zarei-Ghanavati S, Malaekeh-Nikouei B, Pourmazar R, Seyedi S.
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):502-6. PubMed ID: 22537291
    [Abstract] [Full Text] [Related]

  • 2. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M, Li X, Liu J, Han Y, Cheng L.
    J Control Release; 2015 Apr 10; 203():109-17. PubMed ID: 25700623
    [Abstract] [Full Text] [Related]

  • 3. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J, Lan B, Li X, Sun S, Lu P, Cheng L.
    J Control Release; 2016 Dec 10; 243():78-85. PubMed ID: 27717742
    [Abstract] [Full Text] [Related]

  • 4. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC, Messias A, Siqueira RC, Bonini-Filho MA, Haddad A, Damico FM, Maia-Filho A, Crispim PT, Saliba JB, Ribeiro JA, Scott IU, Cunha AS, Jorge R.
    Curr Eye Res; 2012 Jan 10; 37(1):55-61. PubMed ID: 22029458
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal pharmacokinetics after posterior subtenon triamcinolone acetonide injection in vitrectomized rabbit eyes.
    Park HJ, Lee JE, Kim SI, Pak KY, Oum BS, Lee JS, Jung JH, Lee JE.
    Retina; 2014 Apr 10; 34(4):801-6. PubMed ID: 24077088
    [Abstract] [Full Text] [Related]

  • 6. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
    Cheng L, Banker AS, Martin M, Kozak I, Freeman WR.
    Ophthalmology; 2009 Jul 10; 116(7):1356-9. PubMed ID: 19450879
    [Abstract] [Full Text] [Related]

  • 7. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA, Cej A, Jonas JB.
    Ophthalmology; 2008 Aug 10; 115(8):1372-5. PubMed ID: 18355920
    [Abstract] [Full Text] [Related]

  • 8. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
    Kaji Y, Hiraoka T, Okamoto F, Asano H, Oshika T.
    Acta Ophthalmol; 2008 Feb 10; 86(1):97-102. PubMed ID: 17908254
    [Abstract] [Full Text] [Related]

  • 9. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T, Uemura A, Kita H, Sakamoto T.
    J Glaucoma; 2007 Mar 10; 16(2):220-4. PubMed ID: 17473734
    [Abstract] [Full Text] [Related]

  • 10. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M, Takeda K, Morita K, Yamada M, Tanigawara Y, Oguchi Y.
    Am J Ophthalmol; 2004 Dec 10; 138(6):1046-8. PubMed ID: 15629301
    [Abstract] [Full Text] [Related]

  • 11. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
    Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB, Miller M.
    Ophthalmology; 2003 Apr 10; 110(4):681-6. PubMed ID: 12689886
    [Abstract] [Full Text] [Related]

  • 12. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
    Yi NY, Davis JL, Salmon JH, Gilger BC.
    Vet Ophthalmol; 2008 Sep 10; 11 Suppl 1():15-9. PubMed ID: 19046265
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.
    McGee DH, Dembinska O, Gruebbel MM.
    Int J Toxicol; 2005 Sep 10; 24(6):419-25. PubMed ID: 16393934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.
    Song Z, Gong Y, Liu H, Ren Q, Sun X.
    Mol Vis; 2011 Sep 10; 17():2056-64. PubMed ID: 21850181
    [Abstract] [Full Text] [Related]

  • 17. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS, Tyagi P, Edelhauser HF, Kompella UB.
    Int J Pharm; 2012 Sep 15; 434(1-2):140-7. PubMed ID: 22633904
    [Abstract] [Full Text] [Related]

  • 18. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
    Bakri SJ, Beer PM.
    Ophthalmic Surg Lasers Imaging; 2003 Sep 15; 34(5):386-90. PubMed ID: 14509462
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes.
    Mason JO, Somaiya MD, Singh RJ.
    Retina; 2004 Dec 15; 24(6):900-4. PubMed ID: 15579987
    [Abstract] [Full Text] [Related]

  • 20. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM, Lim JO, Kim HK, Kim SY, Shin JP.
    Eur J Pharm Biopharm; 2008 Sep 15; 70(1):179-86. PubMed ID: 18667297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.